Regression of Peripheral Subclinical Enthesopathy in Therapy-Naive Patients Treated With Ustekinumab for Moderate-to-Severe Chronic Plaque Psoriasis: A Fifty-Two–Week, Prospective, Open-Label Feasibility Study

Laura Savage, Mark Goodfield, Laura Horton, Abdulla Watad, Elizabeth Hensor, Paul Emery, Richard Wakefield, Miriam Wittmann, Dennis McGonagle

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Regression of Peripheral Subclinical Enthesopathy in Therapy-Naive Patients Treated With Ustekinumab for Moderate-to-Severe Chronic Plaque Psoriasis: A Fifty-Two–Week, Prospective, Open-Label Feasibility Study'. Together they form a unique fingerprint.

Medicine & Life Sciences